|
全民健康保險藥品給付規定 / 健保碼及健保價 |
|
See related Survanta intratracheal susp[守肺佳 氣管吸入懸液劑] information |
|
|
|
製造商 |
Abbott |
|
代理/經銷商 |
Abbott |
|
成份 |
Beractant (equiv to phospholipids 25 mg/mL, 0.5-1.75 mg/mL triglycerides, 1.4-3.5 mg/mL free fatty acids, <1 mg/mL protein) |
|
適應症 |
Prevention & treatment of respiratory distress syndrome in premature infants. |
|
用量 |
100 mg of phospholipids/kg birthweight (4 mL/kg birthweight). |
|
過量 |
View Survanta[守肺佳] overdosage for action to be taken in the event of an overdose. |
|
禁忌 |
[Click for Survanta[守肺佳] detailed prescribing infomation] |
|
警告 |
For additional cautionary notes to warn of the potential risk of using the medicine... click to view Survanta[守肺佳] detailed prescribing infomation |
|
注意事項 |
Infants < 600 g. For intratracheal use only. Monitor arterial or transcutaneous measurement of systemic oxygen & carbon dioxide. |
|
不良反應 |
Transient bradycardia. O2 desaturation, endotracheal tube reflux, pallor, vasoconstriction, hypotension, endotracheal tube blockage, HTN, hypocarbia, hypercarbia, apnea.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
儲存 |
View Survanta[守肺佳] storage conditions for details to ensure optimal shelf-life. |
|
描述 |
View Survanta[守肺佳] description for details of the chemical structure and excipients (inactive components). |
|
作用 |
View Survanta[守肺佳] mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
本商品之市售規格 |
|
劑型 |
包裝 |
圖片 |
|
Survanta 氣管吸入懸液劑 |
|
Survanta 25 mg/1 mL x 8 mL |
 |
|
|
|
Manufacturer: |
Abbott |
|
Distributor: |
Abbott |
|
|
|
|
